- Home
- CYTK vs TKC Comparison
CYTK vs TKC Comparison
Compare CYTK & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- TKC
- Stock Information
- Founded
- CYTK 1997
- TKC 1993
- Country
- CYTK United States
- TKC Turkey
- Employees
- CYTK N/A
- TKC N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- TKC Telecommunications Equipment
- Sector
- CYTK Health Care
- TKC Telecommunications
- Exchange
- CYTK Nasdaq
- TKC Nasdaq
- Market Cap
- CYTK 5.6B
- TKC 5.2B
- IPO Year
- CYTK 2004
- TKC 2000
- Fundamental
- Price
- CYTK $32.48
- TKC $5.95
- Analyst Decision
- CYTK Buy
- TKC
- Analyst Count
- CYTK 19
- TKC 0
- Target Price
- CYTK $77.33
- TKC N/A
- AVG Volume (30 Days)
- CYTK 2.4M
- TKC 835.1K
- Earning Date
- CYTK 05-06-2025
- TKC 05-27-2025
- Dividend Yield
- CYTK N/A
- TKC 2.92%
- EPS Growth
- CYTK N/A
- TKC 29.85
- EPS
- CYTK N/A
- TKC 0.30
- Revenue
- CYTK $19,218,000.00
- TKC $4,712,370,643.00
- Revenue This Year
- CYTK $55.84
- TKC $30.06
- Revenue Next Year
- CYTK $646.96
- TKC $30.03
- P/E Ratio
- CYTK N/A
- TKC $7.65
- Revenue Growth
- CYTK 412.21
- TKC 7.77
- 52 Week Low
- CYTK $31.67
- TKC $5.49
- 52 Week High
- CYTK $68.44
- TKC $8.47
- Technical
- Relative Strength Index (RSI)
- CYTK 31.23
- TKC 45.61
- Support Level
- CYTK $34.88
- TKC $5.66
- Resistance Level
- CYTK $43.51
- TKC $5.92
- Average True Range (ATR)
- CYTK 2.00
- TKC 0.11
- MACD
- CYTK -0.67
- TKC 0.01
- Stochastic Oscillator
- CYTK 6.84
- TKC 46.77
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About TKC Turkcell Iletisim Hizmetleri AS
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, Netherlands, and Ukraine. It has three main reportable segments, Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment that derives the majority of revenue comprises mainly telecommunication and technology services activities.